Masimo Corp. (NASDAQ:MASI) shares reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $59.72 and last traded at $59.21, with a volume of 279,715 shares traded. The stock had previously closed at $58.24.

Several research analysts have recently issued reports on MASI shares. Raymond James Financial Inc. downgraded shares of Masimo Corp. from a “strong-buy” rating to an “outperform” rating in a report on Wednesday, June 1st. Wedbush upped their target price on shares of Masimo Corp. from $51.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, May 5th. BTIG Research reissued a “hold” rating on shares of Masimo Corp. in a research note on Friday, August 5th. Zacks Investment Research raised shares of Masimo Corp. from a “hold” rating to a “buy” rating and set a $51.00 target price on the stock in a research note on Friday, May 6th. Finally, Piper Jaffray Cos. reissued an “overweight” rating and issued a $55.00 target price (up previously from $52.00) on shares of Masimo Corp. in a research note on Friday, August 5th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Masimo Corp. presently has an average rating of “Buy” and an average price target of $52.60.

The stock has a market cap of $2.90 billion and a PE ratio of 30.82. The company’s 50-day moving average price is $53.69 and its 200-day moving average price is $45.88.

Masimo Corp. (NASDAQ:MASI) last released its earnings results on Wednesday, August 3rd. The company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.41 by $0.16. The firm earned $172.64 million during the quarter, compared to the consensus estimate of $166.02 million. During the same period in the prior year, the business earned $0.36 earnings per share. Masimo Corp.’s quarterly revenue was up 10.9% compared to the same quarter last year. Equities research analysts predict that Masimo Corp. will post $2.02 EPS for the current year.

In other Masimo Corp. news, CFO Raad Mark De sold 40,000 shares of the firm’s stock in a transaction dated Tuesday, May 31st. The shares were sold at an average price of $49.43, for a total value of $1,977,200.00. Following the transaction, the chief financial officer now directly owns 42,660 shares of the company’s stock, valued at approximately $2,108,683.80. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Paul Jansen sold 10,000 shares of the firm’s stock in a transaction dated Thursday, August 4th. The shares were sold at an average price of $58.88, for a total transaction of $588,800.00. Following the completion of the transaction, the executive vice president now directly owns 10,000 shares in the company, valued at $588,800. The disclosure for this sale can be found here.

A number of institutional investors have recently added to or reduced their stakes in the stock. New York State Common Retirement Fund raised its position in Masimo Corp. by 2.0% in the fourth quarter. New York State Common Retirement Fund now owns 65,782 shares of the company’s stock valued at $2,731,000 after buying an additional 1,300 shares in the last quarter. Principal Financial Group Inc. increased its stake in Masimo Corp. by 2.9% in the fourth quarter. Principal Financial Group Inc. now owns 307,924 shares of the company’s stock worth $12,782,000 after buying an additional 8,534 shares during the last quarter. Morgan Stanley increased its stake in Masimo Corp. by 3.1% in the fourth quarter. Morgan Stanley now owns 520,406 shares of the company’s stock worth $21,601,000 after buying an additional 15,718 shares during the last quarter. Trexquant Investment LP bought a new stake in Masimo Corp. during the fourth quarter worth $1,009,000. Finally, State of Tennessee Treasury Department increased its stake in Masimo Corp. by 41.6% in the fourth quarter. State of Tennessee Treasury Department now owns 155,800 shares of the company’s stock worth $6,467,000 after buying an additional 45,800 shares during the last quarter.

Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.